Literature DB >> 8676340

Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.

G Xie1, R Gupta, K Atchison, J W Lown.   

Abstract

The synthesis, characterization, inhibitory activity against topoisomerase I, and biological evaluation of a series of oligopeptide-substituted bisindolylmaleimides 7-12 are described. Compounds 7-9, which contain a basic C-terminus function such as (dimethylamino)propyl and bind to DNA with C(50) values of 200, 160, and 135 microM, respectively, exhibited inhibition of topoisomerase I in a concentration dependent manner. Also, the relative order of observed topoisomerase I inhibition is 9 > 8 > 7 at < or = 100 microM concentration, corresponding to the increase of the number of pyrrole units in the oligopeptide moiety. Compounds 10-12, which contain an electrostatically neutral moiety, such as methyl ester, did not bind to DNA templates nor inhibit topoisomerase I. However, the cytotoxicity activities of these compounds were 1.5 times greater than those of compounds 7-9.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676340     DOI: 10.1021/jm950465d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Topoisomerase I inhibitors and drug resistance.

Authors:  R E Parchment; A Pessina
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Triostin A derived hybrid for simultaneous DNA binding and metal coordination.

Authors:  Eike-F Sachs; André Nadler; Ulf Diederichsen
Journal:  Amino Acids       Date:  2010-10-22       Impact factor: 3.520

3.  Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia.

Authors:  Xin Zhang; Deyong Jia; Junping Ao; Huijuan Liu; Yi Zang; Mohammad Azam; Samy L Habib; Jia Li; Xinsen Ruan; Hao Jia; Xueying Wang; Baojie Li
Journal:  Oncotarget       Date:  2016-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.